LIQUIDITY ALERT: Samaritan’s Current Deficit Up by US$5.3 Million
Samaritan Pharmaceuticals, Inc.’s working capital deficit increased by 1,800%, or US$5,294,588, to US$5,588,759 at Dec. 31, 2008, from US$294,171 at Dec. 31, 2007.
The Company reported US$3,229,837 in current assets and…